Get all your news in one place.
100's of premium titles.
One app.
Start reading
Birmingham Post
Birmingham Post
Business
Jon Robinson

Company backed by Caffè Nero and Gulfstream investor secures $70m boost

A $70m boost has been secured by a Manchester-headquartered clinical-stage biopharmaceutical company, which is backed by a range of investors in the likes of Caffè Nero and Gulfstream.

F2G Ltd has received the backing from Forbion and Sofinnova Partners as well existing investors Novo Holdings, Morningside Ventures, Cowen Healthcare Investments and Advent Life Sciences.

The financing comes after the company recently agreed a $480m "strategic collaboration" with Shionogi & Co Ltd.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.